Hospitalizations and common infections among veterans treated for metastatic prostate cancer.

被引：0
|
作者：
Riekhof, Forest [1 ]
Luo, Suhong [1 ]
Cheranda, Nina [1 ]
Govindan, Srinivas [1 ]
Sanfilippo, Kristen Marie [1 ]
Schoen, Martin W. [1 ]
机构：
[1] St Louis Vet Affairs Med Ctr, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 06期
关键词：
D O I：
10.1200/JCO.2022.40.6_suppl.092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Risk factors for clinical fractures among men with non-metastatic prostate cancer.
    Duh, MS
    Smith, MR
    Boyce, SP
    Moyneur, E
    Raut, MR
    Brandman, J
    Sung, JC
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
  • [22] A novel artificial intelligence biomarker: Validation of the automated bone scan index (aBSI) in veterans with metastatic prostate cancer.
    Durkal, Vipal P.
    Nickols, Nicholas George
    Rettig, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Factors associated with gene mutation testing in United States veterans with metastatic castration-resistant prostate cancer.
    Hung, Anna
    Li, Yanhong
    Candelieri, Danielle
    Alba, Patrick
    Anglin-Foote, Tori
    Lee, Kyung Min
    Agiri, Fatai
    Perez, Cristina
    Li, Weiyan
    Amin, Suvina
    Jiang, Shan
    DuVall, Scott L.
    Wong, Yu-Ning
    Reed, Shelby D.
    Lynch, Julie Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [24] Prognosis stratification by a mutational signature in metastatic prostate cancer.
    Zhang, Gejun
    Liu, Huanhuan
    Qin, Jiayue
    Cao, Shanbo
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Targeted nanoparticle approach to treating metastatic prostate cancer.
    Gdowski, Andrew
    Ranjan, Amalendu
    Sarker, Marjana
    Vishwanatha, Jamboor
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 89 - 90
  • [26] Urinary osteopontin as a marker for localized and metastatic prostate cancer.
    Prager, A. J.
    Peng, C. R.
    Lita, E.
    McNally, D.
    Kaushal, A.
    Sproull, M.
    Compton, K.
    Dahut, W. L.
    Figg, W. D.
    Camphausen, K. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Heterogeneous bone histomorphometric patterns in metastatic prostate cancer.
    Roudier, MP
    Sherrard, DJ
    True, LD
    Ott-Ralph, SM
    Meligro, C
    Berrie, M
    Soo, CCY
    Felise, DG
    Quinn, JE
    Vessella, RL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S567 - S567
  • [28] Study of the immuno-microenvironment in metastatic prostate cancer.
    Gannon, P
    Bellon-Gagnon, P
    Lapointe, R
    Mes-Masson, AM
    Saad, F
    JOURNAL OF UROLOGY, 2005, 173 (04): : 115 - 115
  • [29] The use of bisphosphonates in the management of bone metastatic prostate cancer.
    Mercadante S.
    Current Urology Reports, 2002, 3 (3) : 244 - 249
  • [30] Use of hormonal therapy in men with metastatic prostate cancer.
    Lu-Yao, GL
    Moore, DF
    Dipaola, RS
    Yao, SL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
12345